Devyser secures SEK 8.9M five-year tender and strengthens Italian position
Devyser, a leading provider of advanced genetic testing solutions, has been awarded a tender in...
.jpg)
Devyser launches the first IVDR compliant NGS assay for thalassemia and sickle cell disease testing
Devyser, today announced the launch of Devyser Thalassemia v2, the first Next-Generation Sequencing...
Devyser acquires Swedish company Cybergene AB and strengthens its position in the aneuploidy market
Devyser Diagnostics AB (publ), a Swedish molecular diagnostics company, today announces that it has...
Devyser enters Strategic Supply Agreement with Illumina to offer sequencing instruments and products
Devyser today announced that it entered a strategic agreement with Illumina, a global leader in DNA...